Michael O. Fleming is Chief Medical Officer at AMEDISYS INC (AMED). They have made 1 open-market trade across 1 company since 2013, most recently 2015-04-01.
CIK 0001475320
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMED | 19,952 | $2.0M |
Shares reported on the most recent Form 4, priced at the 2015-04-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMED | SELL | 2013-05-03 | 2013-05-06 | $10.10 | $10K | -6.2% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.